Literature DB >> 12354890

Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection.

Corey Casper1, Elizabeth Krantz, Heather Taylor, Julie Dalessio, David Carrell, Anna Wald, Lawrence Corey, Rhoda Ashley.   

Abstract

The performance of a human herpesvirus 8 (HHV-8) enzyme immunoassay (EIA) and selective subsequent use of an HHV-8 immunofluorescence assay (IFA) was tested in persons unlikely to be infected with HHV-8 and those who had HHV-8 detected in their saliva. The IFA was performed on samples within a range of EIA optical densities (0.15 to 0.35) where there was considerable overlap between HHV-8-infected and uninfected individuals. The sensitivity of the testing strategy was 88%, with a specificity of 97%.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354890      PMCID： PMC130660          DOI： 10.1128/JCM.40.10.3822-3825.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies.

Authors:  J N Martin; Z Amad; C Cossen; P K Lam; D H Kedes; K A Page-Shafer; D H Osmond; B Forghani
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates.

Authors:  D M Koelle; M L Huang; B Chandran; J Vieira; M Piepkorn; L Corey
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

4.  Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy.

Authors:  D Whitby; M Luppi; P Barozzi; C Boshoff; R A Weiss; G Torelli
Journal:  J Natl Cancer Inst       Date:  1998-03-04       Impact factor: 13.506

5.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.

Authors:  M Enbom; J Sheldon; E Lennette; T Schulz; D V Ablashi; F Neipel; P Biberfeld; H Carlberg; P Ljungman; A Nilsson; T Söderström; J Wadström; A Linde
Journal:  J Med Virol       Date:  2000-12       Impact factor: 2.327

7.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

8.  Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.

Authors:  B Chandran; M S Smith; D M Koelle; L Corey; R Horvat; E Goldstein
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

9.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

10.  Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples.

Authors:  A J Ryncarz; J Goddard; A Wald; M L Huang; B Roizman; L Corey
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948
View more
  10 in total

1.  Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.

Authors:  Ashok Cattamanchi; Misty Saracino; Stacy Selke; Meei-Li Huang; Amalia Magaret; Connie Celum; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

2.  HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.

Authors:  C Casper; D Carrell; K G Miller; F D Judson; A S Meier; J S Pauk; R A Morrow; L Corey; A Wald; C Celum
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.

Authors:  Corey Casper; Elizabeth Krantz; Stacy Selke; Steven R Kuntz; Jie Wang; Meei-Li Huang; John S Pauk; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2006-11-14       Impact factor: 5.226

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.

Authors:  Melanie M Taylor; Bhavna Chohan; Ludo Lavreys; Wisal Hassan; Meei-Li Huang; Larry Corey; Rhoda Ashley Morrow; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah Ndinya-Achola; Job Bwayo; Joan Kreiss
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

6.  Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.

Authors:  Juan V Guanira; Corey Casper; Javier R Lama; Rhoda Morrow; Silvia M Montano; Patricia Caballero; Luis Suárez; William L H Whittington; Anna Wald; Jorge Sanchez; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

7.  Development of whole-virus multiplex luminex-based serological assays for diagnosis of infections with kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 homologs in macaques.

Authors:  Jonathan T Ryan; Timothy M Rose
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

8.  Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.

Authors:  Soren Gantt; Ashok Cattamanchi; Elizabeth Krantz; Amalia Magaret; Stacy Selke; Steven R Kuntz; Meei-Li Huang; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Clin Virol       Date:  2014-03-13       Impact factor: 3.168

9.  Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Sherwin Lee; Owen Wood; Bih Awazi; Indira K Hewlett
Journal:  Viruses       Date:  2013-09-19       Impact factor: 5.048

10.  Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.

Authors:  Rachel A Bender Ignacio; Jason D Goldman; Amalia S Magaret; Stacy Selke; Meei-Li Huang; Soren Gantt; Christine Johnston; Warren T Phipps; Joshua T Schiffer; Richard A Zuckerman; R Scott McClelland; Connie Celum; Larry Corey; Anna Wald; Corey Casper
Journal:  Infect Agent Cancer       Date:  2016-02-10       Impact factor: 2.965
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.